Our data presented here provides evidence that elevated expression of Gadd45a correlates with ER+/PR+, Luminal A and Luminal B breast cancers, whereas low expression of Gadd45a correlates with ER-/PR-, Her2+ and Triple Negative breast cancers. This evidence concerns the gene GADD45A and breast cancer.